About this Journal Submit a Manuscript Table of Contents
Advances in Urology
Volume 2013 (2013), Article ID 471234, 5 pages
http://dx.doi.org/10.1155/2013/471234
Research Article

Differences in Upgrading of Prostate Cancer in Prostatectomies between Community and Academic Practices

1Department of Urology, University of Washington School of Medicine, Health Sciences Building, 1959 NE Pacific, BB-1115, P.O. Box 356510, Seattle, WA 98195, USA
2Department of Pathology, University of Washington School of Medicine, Seattle, WA 98195, USA
3Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA

Received 11 July 2013; Accepted 5 September 2013

Academic Editor: William K. Oh

Copyright © 2013 Franklin Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Objective. To determine whether initial biopsy performed by community or academic urologists affected rates of Gleason upgrading at a tertiary referral center. Gleason upgrading from biopsy to radical prostatectomy (RP) is an important event as treatment decisions are made based on the biopsy score. Materials and Methods. We identified men undergoing RP for Gleason or disease at a tertiary care academic center. Biopsy performed in the community was centrally reviewed at the academic center. Multivariate logistic regression was used to determine factors associated with Gleason upgrading. Results. We reviewed 1,348 men. There was no difference in upgrading whether the biopsy was performed at academic or community sites (OR 0.9, 95% CI 0.7–1.2). Increased risk of upgrading was seen in those with >1 positive core, older men, and those with higher PSAs. Secondary pattern 4 and larger prostate size were associated with a reduction in risk of upgrading. Compared to the smallest quartile of prostate size (<35 g), those in the highest quartile (>56 g) had a 49% reduction in risk of upgrading (OR 0.51, 95% CI 0.3–0.7). Conclusion. There was no difference in upgrading between where the biopsy was performed and community and academic urologists.